T1D Exchange is a nonprofit dedicated to improving outcomes for the entire T1D population through driving real-world evidence and collaborative change.
Your experiences matter. By sharing your perspective, answering Question of the Day, participating in #research, and engaging with our community, you're helping drive progress in #T1D.
Stay connected: https://t.co/cePscwogcI
Researchers are studying a nighttime injection to see if it can reduce overnight lows.
Adults 18-75 with T1D for over 5 years might be eligible for the clinical trial for this new treatment.
10 new U.S. locations are now open! 🌟
See if you're eligible: https://t.co/UzU9HTlCFd
After 13 years of living with #T1D, Katie Beth Hand did something she never imagined possible: She stopped taking #insulin.
Read her full story now: https://t.co/kaw74N6nRW
#clinicaltrial#diabetesresearch
Do you have T1D and a history of severe lows?
Vertex Pharmaceuticals’ VX-880-101 clinical trial is currently recruiting people with T1D ages 18-65. This study is evaluating an investigational islet cell therapy in T1D.
See if you may be eligible: https://t.co/7Mexyh08s7
We are excited to share that T1D Exchange has launched a refreshed #brand and new website.
The update reflects how we work today—bringing together real-world data, research, and community insight to improve care for people living with #type1diabetes.
➡️https://t.co/KHGV0PRyRQ
We’re excited to introduce the T1D Exchange Medical & Research Advisory Team — leading diabetes experts helping shape the future of T1D care through research, innovation, and quality improvement.
Learn more: https://t.co/KTTVjYtB2u
Survey opportunity! Researchers are looking for youth with T1D who are not going to a summer camp specifically for kids with diabetes this year. Families who participate will take a series of quick surveys. See if you’re eligible: https://t.co/qwiOvX12wV
Technology has transformed #T1D management — but there’s still more work ahead.
In our latest Meet the Expert feature, Jennifer Sherr, MD, shares insights on innovation, quality improvement, and the future of diabetes care.
https://t.co/wvRZUWbjWo
Your experience with type 1 diabetes matters.
Join the T1D Exchange Registry to share what life with T1D really looks like—through quick surveys and optional research opportunities.
23,000+ people are already in!
Make your voice heard: https://t.co/S1mCrB1Orf
GLP-1 medications are gaining traction in the T1D community. Check out what you need to know from expert Diana Isaacs, who breaks down the real-world benefits and risks of GLP-1 medications in type 1 diabetes.
https://t.co/dQsDkqPZi8
The VX-880-101 clinical trial is still enrolling participants!
This study tests an investigational cell therapy for people with #T1D and severe lows/impaired awareness of lows.
Learn more and check eligibility: https://t.co/WGytRIRZ4b
Living with #T1D and experiencing nighttime lows?
You could be eligible for a study targeting overnight hypoglycemia.
- 10 new locations opened!
- 18-75 years old
- Must have T1D for 5+ years
👉 Interested? Complete the questionnaire: https://t.co/mmI0reTKIC
New study sites added! If you are an adult with T1D and you have recently experienced low blood glucose levels, you may now qualify for a clinical trial studying a drug that may help reduce lows and lower A1C.
Find a study site near you and learn more: https://t.co/LD4CRrdU1x
Good news for families navigating early-stage type 1 diabetes (T1D)!
The U.S. FDA has now approved teplizumab (Tzield) for children as young as 1 year old with stage 2 T1D, with the goal of delaying progression to stage 3.
Learn more from Sanofi:
https://t.co/6HX7LW0em1
Caring for a child with T1D comes with lessons no textbook can teach.
Share your family’s experience through the T1D Exchange Registry to help improve care for people with T1D. Your story can pave the way for future research advancements. Join us today: https://t.co/k6YC2672Ck
New study opportunity! Researchers are looking for youth with #T1D ages 8 to 17 who are not attending a diabetes camp this summer -- and their caregivers -- to take a series of brief surveys.
Learn more: https://t.co/exuaFNuycy
Are you experiencing nighttime lows with #T1D?
You may qualify for a Phase 2 clinical trial for an investigational medication.
- Ages 18-75
- Living with T1D for 5+ years
📍 10 new study locations!
Take our quick questionnaire: https://t.co/SE1xdn0A20
The T1DX-QI Leadership Committee brings together experts across 60+ centers to turn insights into real-world impact—advancing early detection, improving access to technology, and reducing disparities in care.
https://t.co/SGkACt8NnZ
#T1D#Innovation
Every breakthrough starts with real people and real experiences.
Join the T1D Exchange Registry to help advance research and care for type 1 diabetes. Share your story, participate in studies, and make a difference: https://t.co/bHoV3H7wK9
“How can diabetes technology be more reachable and understandable for everyone?”
Dr. Jenise Wong shares how equity, access, and connection are shaping the future of diabetes care.
Read more: https://t.co/sq12oCkrRq